Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

• Main Authors: Bang, Yung-Jue, Su, Wu-Chou, Schuler, Martin, Nam, Do-Hyun, Lim, Wan Teck, Bauer, Todd M, Azaro, Analia, Poon, Ronnie Tung Ping, Hong, David, Lin, Chia-Chi, Akimov, Mikhail, Ghebremariam, Samson, Zhao, Sylvia, Giovannini, Monica, Ma, Brigette
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Language: English
• Published: WILEY 2022
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; capmatinib; MET amplification; MET dysregulation; phase 1; solid tumors; CELL LUNG-CANCER; MOLECULE INHIBITORS BINDING; C-MET; PHARMACOPHORE APPROACH; ACQUIRED-RESISTANCE; KINASE INHIBITOR; TARGETING MET; AMPLIFICATION; SENSITIVITY; MUTATIONS
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/218537
• Institution: National University of Singapore

10.1111/cas.14254